1. Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the 'select-d' Pilot Trial. Issue 164 (April 2018) Authors: Young, A.; Marshall, A.; Thirlwall, J.; Chapman, O.; Lokare, A.; Hill, C.; Hale, D.; Dunn, J.A.; Kakkar, A.K.; Levine, M. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism. Issue 140 (April 2016) Authors: Young, A.; Phillips, J.; Hancocks, H.; Hill, C.; Joshi, N.; Marshall, A.; Grumett, J.; Dunn, J.A.; Lokare, A.; Chapman, O. Journal: Thrombosis research Issue: Issue 140(2016)Supplement 1 Page Start: S172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial. Issue 200 (April 2021) Authors: Marshall, A.; Young, A.M.; Levine, M.; Hill, C.; Hale, D.; Thirlwall, J.; Wilkie, V.; French, K.; Kakkar, A.K.; Lokare, A.; Maraveyas, A.; Chapman, O.; Arif, A.; Petrou, S.; Maredza, M.; Hobbs, F.D.R.; Dunn, J.A. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗